| Financial Year |
March 31 2023 |
| Monetary Funds |
1,360,773,123.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
83,468,218.11 |
| Accounts Receivable |
224,463,261.22 |
| Advances to Suppliers |
280,610,649.25 |
| Other Receivables |
56,127,695.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
557,279,468.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,078,145.55 |
| Total Current Assets |
3,481,641,225.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
227,629,015.55 |
| Investment Properties |
3,251,581.73 |
| Fixed Assetes |
7,142,750,443.02 |
| Under-construction Projects |
710,352,007.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,072,002,140.97 |
| R&D expenses |
-- |
| Goodwill |
6,437,701.74 |
| Long-Term Deferred and Prepaid Expenses |
26,127,868.13 |
| Deferred Income Tax Assets |
46,326,455.92 |
| Other Non-Current Assets |
24,630,030.39 |
| Sub-Total of Non-Current Assets |
9,272,433,774.41 |
| Total Assets |
12,754,075,000.02 |
| Short-Term Loans |
7,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
110,228,538.00 |
| Accounts Payable |
152,917,577.53 |
| Accounts Received In Advance |
1,518,958.20 |
| Employee Compensation Payable |
3,434,261.17 |
| Taxes Payable |
27,302,834.69 |
| Interest Payable |
1,900,381.85 |
| Dividend Payable |
3,643.29 |
| Other payables |
830,576,743.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
527,381,565.48 |
| Other Current Liabilities |
25,812,440.92 |
| Sub-Total of Current Liabilities |
2,116,380,268.54 |
| Long-term Loans |
3,234,600,967.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
96,045,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,048,892.65 |
| Other Non-Current Liabilities |
427,718.10 |
| Sub-Total of Non-Current Liabilities |
3,570,992,963.84 |
| Total Liabilities |
5,687,373,232.38 |
| Paid-In Capital(Or Share Stock) |
1,186,866,283.00 |
| Capital Surplus |
3,294,662,025.86 |
| Surplus Reserve |
163,843,526.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,001,866,781.21 |
| Minority Stockholder's Interest |
1,379,310,356.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,687,391,410.83 |
| Owner's Equity（Stockholder's Equity） |
7,066,701,767.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,754,075,000.02 |
